Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel

Abstract Selatogrel is a potent and selective reversible P2Y12 receptor antagonist in development for early treatment of acute myocardial infarction via subcutaneous (s.c.) self‐injection. Selatogrel is almost exclusively eliminated via the hepatobiliary route. Hepatic impairment is associated with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Uta Schilling (Autor), Chih‐Hsuan Hsin (Autor), Stephane Delahaye (Autor), Andreas Krause (Autor), Hauke Wuelfrath (Autor), Atef Halabi (Autor), Jasper Dingemanse (Autor)
Formato: Livro
Publicado em: Wiley, 2022-08-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível